Becton Dickinson Price to Free Cash Flow Ratio 2010-2024 | BDX

Historical price to free cash flow ratio values for Becton Dickinson (BDX) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Becton Dickinson Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2025-02-14 224.80 20.97
2024-09-30 239.98 $10.72 22.39
2024-06-30 231.70 $11.28 20.55
2024-03-31 244.35 $10.51 23.25
2023-12-31 239.82 $4.66 51.46
2023-09-30 253.24 $4.41 57.38
2023-06-30 257.73 $2.32 110.92
2023-03-31 240.78 $-0.53 0.00
2022-09-30 215.11 $5.21 41.26
2022-06-30 237.19 $12.29 19.30
2022-03-31 248.74 $11.48 21.66
2021-12-31 234.40 $12.39 18.92
2021-09-30 228.31 $14.36 15.90
2022-12-31 246.39 $9.38 26.26
2021-06-30 225.16 $11.27 19.99
2021-03-31 224.34 $12.33 18.19
2020-12-31 230.08 $10.10 22.77
2020-09-30 213.21 $7.68 27.77
2020-06-30 218.51 $8.80 24.82
2020-03-31 209.17 $9.08 23.02
2019-12-31 246.74 $10.32 23.92
2019-09-30 228.79 $8.64 26.49
2019-06-30 227.27 $8.86 25.66
2019-03-31 224.48 $7.57 29.67
2018-12-31 201.91 $7.11 28.39
2018-09-30 233.12 $7.44 31.31
2018-06-30 213.34 $7.36 28.97
2018-03-31 192.36 $6.97 27.60
2017-12-31 189.38 $7.84 24.16
2017-09-30 172.76 $8.15 21.19
2017-06-30 171.39 $6.25 27.44
2017-03-31 160.53 $6.64 24.18
2016-12-31 144.30 $6.54 22.07
2016-09-30 155.97 $7.35 21.21
2016-06-30 146.63 $5.79 25.31
2015-09-30 113.26 $5.46 20.72
2015-06-30 120.39 $4.98 24.16
2015-03-31 121.52 $2.56 47.55
2014-12-31 117.29 $3.75 31.25
2014-09-30 95.51 $4.33 22.05
2016-03-31 130.75 $3.52 37.16
2014-06-30 98.82 $6.84 14.44
2014-03-31 97.35 $6.73 14.46
2013-12-31 91.44 $6.21 14.73
2013-09-30 82.36 $5.67 14.53
2013-06-30 80.97 $4.72 17.16
2013-03-31 77.94 $5.45 14.31
2012-12-31 63.38 $5.27 12.03
2012-09-30 63.27 $5.45 11.61
2012-06-30 59.85 $5.03 11.90
2012-03-31 61.79 $4.05 15.25
2011-12-31 59.11 $3.83 15.42
2011-09-30 57.64 $4.59 12.55
2011-06-30 67.40 $4.35 15.51
2011-03-31 61.98 $4.59 13.49
2010-12-31 65.46 $4.63 14.13
2010-09-30 57.10 $4.00 14.27
2010-06-30 51.83 $4.39 11.82
2010-03-31 60.03 $4.43 13.55
2009-12-31 59.84 $3.35 17.86
2009-09-30 52.68 $3.90 13.49
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $65.893B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.132B 20.57
Cardinal Health (CAH) United States $30.691B 16.44
West Pharmaceutical Services (WST) United States $23.933B 48.89
Straumann Holding AG (SAUHY) Switzerland $22.435B 0.00
Labcorp (LH) United States $20.721B 17.00
Cooper (COO) United States $19.018B 25.75
Align Technology (ALGN) United States $16.303B 30.98
Henry Schein (HSIC) United States $9.956B 18.97
Merit Medical Systems (MMSI) United States $6.355B 32.46
DENTSPLY SIRONA (XRAY) United States $3.819B 10.38
Patterson (PDCO) United States $2.740B 14.64
CONMED (CNMD) United States $2.081B 16.19
STAAR Surgical (STAA) United States $1.125B 41.51
Lifevantage (LFVN) United States $0.238B 26.38
Pro-Dex (PDEX) United States $0.112B 17.08